Fund profile
Pappas Capital
United States
Leading
About
Pappas Capital is a prominent venture capital firm based in Durham, North Carolina, specializing in investing in next-generation life science, agriculture, and technology companies. Established in 1994 by Art Pappas, the firm has a robust track record of investing in over 90 companies across the United States, Canada, and Asia. Their investments focus on innovative solutions that address significant unmet medical needs and span a wide range of diseases, including cancer and hemophilia. Pappas Capital operates through three primary divisions: Pappas Ventures, Specialized Fund Management, and Translational Medicine. Pappas Ventures is their flagship arm, dedicated to life science investments, particularly in undercapitalized markets. Specialized Fund Management creates and manages custom investment vehicles, while Translational Medicine partners with academic institutions to accelerate the development of scientific discoveries. The firm boasts a seasoned team of investment professionals, including Art Pappas, Elizabeth Kelly, and Barry Myers, who bring extensive experience in pharmaceuticals, biotechnology, and venture capital. This expertise enables Pappas Capital to provide valuable insights and strategic guidance to their portfolio companies, helping them navigate the complexities of drug development and commercialization. Pappas Capital has successfully guided numerous companies to significant exits, including IPOs and acquisitions. Recent investments include companies like VFlow Tech and Enlaza Therapeutics, further emphasizing their commitment to advancing groundbreaking life science technologies.
Details
Highlights
$14.6M
Historical average check
$102M
Historical max check
April 2024
Last investment date
30
Investments
Pharma
Biotech
Healthtech & Wellness
Software & Apps
Energy & Utilities
Other
Showing 0 lists
Contacts
Lists that include this fund